• LAST PRICE
    4.9100
  • TODAY'S CHANGE (%)
    Trending Down-0.2500 (-4.8450%)
  • Bid / Lots
    4.6100/ 1
  • Ask / Lots
    5.1400/ 1
  • Open / Previous Close
    5.1100 / 5.1600
  • Day Range
    Low 4.6325
    High 5.3800
  • 52 Week Range
    Low 3.8200
    High 36.6000
  • Volume
    50,079
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 5.16
TimeVolumePALI
09:32 ET17555.24
09:38 ET6005.195
09:39 ET17785.38
09:41 ET120005.15
09:43 ET5005.36
10:12 ET3505.22
10:30 ET1005.22
10:32 ET4005.16
10:37 ET12725.16
10:42 ET1005.185
10:46 ET1005.14
10:57 ET1005.12
11:06 ET1005.1278
11:08 ET6005.1
11:15 ET1005.08
11:24 ET1005.09
11:40 ET2005.07
11:47 ET1005.14
11:56 ET34935.07
12:00 ET1005.08
12:03 ET7005.1
12:05 ET34345
12:07 ET4004.95
12:09 ET25004.9418
12:30 ET1004.91
12:52 ET1004.91
01:03 ET7884.91
01:44 ET1004.92
01:50 ET1004.95
02:08 ET3044.91
02:11 ET24774.8
02:13 ET1914.8462
02:15 ET2004.82
02:20 ET3004.8
02:29 ET10004.81
02:36 ET1994.77
02:38 ET8734.77
02:40 ET1004.81
02:42 ET2004.7501
02:44 ET1004.68
02:45 ET2354.6325
02:47 ET1004.7499
02:51 ET1004.725
03:03 ET3284.72
03:18 ET1064.75
03:34 ET1004.81
03:38 ET5004.7502
03:57 ET1004.845
03:59 ET1004.91
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPALI
Palisade Bio Inc
4.6M
-0.2x
---
United StatesRGBP
Regen BioPharma Inc
4.3M
-4.6x
---
United StatesHALB
Halberd Corp
5.3M
3.6x
---
United StatesLIPO
Lipella Pharmaceuticals Inc
4.9M
-0.9x
---
United StatesGNPX
Genprex Inc
4.6M
-0.1x
---
United StatesMNKA
Manuka Inc
3.4M
-2.4x
---
As of 2024-05-27

Company Information

Palisade Bio, Inc. is a biopharmaceutical company focused on developing novel therapeutics for serious chronic gastrointestinal diseases. It is engaged in advancing a PALI-2108 for the treatment of IBD, including UC and CD and are researching PALI-1908. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract. UC primarily affects the colon and the rectum. CD can affect any part of the gastrointestinal tract, from the mouth to the anus. PALI-2108 is a prodrug PDE4 inhibitor that operates through a mechanism within colon tissues, targeting the key enzyme phosphodiesterase-4 (PDE4). This enzyme is pivotal in cAMP hydrolysis, and by inhibiting PDE4, intracellular cAMP levels are elevated. This elevation leads to the downregulation of inflammatory cytokines and a reduction in the expression of cell adhesion molecules. By modulating these processes, PALI-2108 prevents the local infiltration and activation of inflammatory cells in the colon tissues.

Contact Information

Headquarters
7750 El Camino Real, Suite 5200CARLSBAD, CA, United States 92009
Phone
858-704-4900
Fax
302-697-4597

Executives

Independent Chairman of the Board
Donald Williams
Chief Executive Officer, Chief Financial Officer, Director
J. D. Finley
Chief Operating Officer
Robert Mcrae
Chief Medical Officer
Mitchell Jones
Independent Director
Margery Fischbein

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.6M
Revenue (TTM)
$0.00
Shares Outstanding
937.6K
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.25
EPS
$-24.67
Book Value
$18.30
P/E Ratio
-0.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.